Andrew J Saxon
#178,934
Most Influential Person Now
Researcher
Andrew J Saxon's AcademicInfluence.com Rankings
Andrew J Saxonengineering Degrees
Engineering
#8295
World Rank
#9816
Historical Rank
Cybernetics
#179
World Rank
#187
Historical Rank
Biomedical Engineering
#841
World Rank
#854
Historical Rank
Applied Physics
#2982
World Rank
#3045
Historical Rank
Andrew J Saxonbiology Degrees
Biology
#14897
World Rank
#18769
Historical Rank
Neuroscience
#2657
World Rank
#2727
Historical Rank
Download Badge
Engineering Biology
Why Is Andrew J Saxon Influential?
(Suggest an Edit or Addition)Andrew J Saxon's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Implications of chronic methamphetamine use: a literature review. (2005) (355)
- Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial. (2014) (310)
- Post-traumatic stress disorder and smoking: a systematic review. (2007) (233)
- Prevalence, Comorbidity, and Prognosis of Mental Health Among US Veterans. (2015) (214)
- Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. (2010) (207)
- Factors affecting willingness to provide buprenorphine treatment. (2009) (161)
- A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence. (2009) (152)
- Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial. (2016) (150)
- Ineffectiveness of AIDS education and HIV antibody testing in reducing high-risk behaviors among injection drug users. (1992) (146)
- Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome. (1996) (138)
- Trauma, symptoms of posttraumatic stress disorder, and associated problems among incarcerated veterans. (2001) (137)
- Improving the rates of quitting smoking for veterans with posttraumatic stress disorder. (2005) (126)
- Buprenorphine tapering schedule and illicit opioid use. (2009) (115)
- Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial. (2001) (114)
- Chronic pain among patients with opioid use disorder: Results from electronic health records data. (2017) (110)
- Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START). (2013) (101)
- High Mortality Among Patients With Opioid Use Disorder in a Large Healthcare System (2017) (101)
- The association of persistent pain with out-patient addiction treatment outcomes and service utilization. (2008) (95)
- Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: a randomized trial. (2013) (93)
- HIV Risk Reduction With Buprenorphine–Naloxone or Methadone: Findings From a Randomized Trial (2014) (78)
- A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder. (2015) (72)
- Some Additional Considerations Regarding the American Society of Addiction Medicine National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. (2016) (72)
- The Addiction Severity Index medical and psychiatric composite scores measure similar domains as the SF-36 in substance-dependent veterans: concurrent and discriminant validity. (2004) (69)
- Brief motivational feedback improves post-incarceration treatment contact among veterans with substance use disorders. (2003) (68)
- A narrative review: The effects of opioids on sleep disordered breathing in chronic pain patients and methadone maintained patients. (2016) (67)
- The Physician Clinical Support System-Buprenorphine (PCSS-B): a Novel Project to Expand/Improve Buprenorphine Treatment (2010) (66)
- Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugs. (2005) (52)
- Buprenorphine therapy for opioid addiction in rural Washington: the experience of the early adopters. (2012) (52)
- Retention in methadone maintenance is associated with reductions in different HIV risk behaviors for women and men. (1996) (52)
- From research to the real world: buprenorphine in the decade of the Clinical Trials Network. (2010) (51)
- Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European American females (2013) (51)
- Analysis of urinary benzodiazepines using solid-phase extraction and gas chromatography-mass spectrometry. (1994) (51)
- Prevalence and trends of benzodiazepine use among Veterans Affairs patients with posttraumatic stress disorder, 2003-2010. (2012) (50)
- An Intronic Variant in OPRD1 Predicts Treatment Outcome for Opioid Dependence in African-Americans (2013) (50)
- Genetic Determinants of Addiction to Opioids and Cocaine (2005) (49)
- An open trial of transdermal nicotine replacement therapy for smoking cessation among alcohol- and drug-dependent inpatients. (1997) (49)
- Slow tapering from methadone maintenance in a program encouraging indefinite maintenance. (2006) (48)
- A double-blind, double-dummy, randomized, prospective pilot study of the partial mu opiate agonist, buprenorphine, for acute detoxification from heroin. (2005) (48)
- Medication-assisted treatment for opioid addiction: methadone and buprenorphine. (2013) (48)
- Acupuncture as an Adjunct to Methadone Treatment Services (1995) (47)
- Needle-use practices among intravenous drug users in an area where needle purchase is legal. (1991) (46)
- Personality disorder subtypes among cocaine and opioid addicts using the Millon Clinical Multiaxial Inventory. (1990) (46)
- A phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawal. (2017) (45)
- Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study. (2016) (45)
- Randomized Trial of Onsite Versus Referral Primary Medical Care for Veterans in Addictions Treatment (2006) (45)
- A Comparison of Methamphetamine-Dependent Inpatients With and Without Childhood Attention Deficit Hyperactivity Disorder Symptomatology (2005) (44)
- Contingency management of urinalysis results and intensity of counseling services have an interactive impact on methadone maintenance treatment outcome. (1995) (44)
- Integrating tobacco cessation treatment into mental health care for patients with posttraumatic stress disorder. (2006) (43)
- Double-Blind Randomized Clinical Trial of Prazosin for Alcohol Use Disorder. (2018) (43)
- Implementation of buprenorphine in the Veterans Health Administration: results of the first 3 years. (2007) (42)
- Clinical evaluation and use of urine screening for drug abuse. (1988) (41)
- Longitudinal sexual behavior changes in injecting drug users (1992) (40)
- Longitudinal changes in injection behaviors in a cohort of injection drug users. (1994) (40)
- Distinctive Trajectories of Opioid Use Over an Extended Follow-up of Patients in a Multisite Trial on Buprenorphine + Naloxone and Methadone. (2017) (40)
- Prevalence and treatment of opioid use disorders among primary care patients in six health systems. (2019) (39)
- Correlates of Long-Term Opioid Abstinence After Randomization to Methadone Versus Buprenorphine/Naloxone in a Multi-Site Trial (2018) (39)
- Integrating smoking cessation into mental health care for post-traumatic stress disorder (2007) (38)
- Prevalence and Trends of Concurrent Opioid Analgesic and Benzodiazepine Use Among Veterans Affairs Patients with Post-traumatic Stress Disorder, 2003-2011. (2015) (38)
- Study results from the Clinical Trials Network's first 10 years: where do they lead? (2010) (36)
- Associations of housing status with substance abuse treatment and service use outcomes among veterans. (2010) (36)
- Pharmacists' and technicians' perceptions and attitudes toward dispensing buprenorphine/ naloxone to patients with opioid dependence. (2005) (36)
- Changes in Millon Clinical Multiaxial Inventory Scores Among Opiate Addicts as a Function of Retention in Methadone Maintenance Treatment and Recent Drug Use (2000) (35)
- An Open-Label Pilot Study of Risperidone in the Treatment of Methamphetamine Dependence (2007) (34)
- An Intronic Variant in OPRD1 Predicts Treatment Outcome for Opioid Dependence in African-Americans (2014) (33)
- Risk reduction in sexual behavior: a condom giveaway program in a drug abuse treatment clinic. (1992) (33)
- Proceedings of the 3rd Biennial Conference of the Society for Implementation Research Collaboration (SIRC) 2015: advancing efficient methodologies through community partnerships and team science (2016) (33)
- Proceedings of the 3rd Biennial Conference of the Society for Implementation Research Collaboration (SIRC) 2015: advancing efficient methodologies through community partnerships and team science (2016) (33)
- Valproic acid, unlike other anticonvulsants, has no effect on methadone metabolism: two cases. (1989) (32)
- High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder (2021) (32)
- Sexual behaviors of intravenous drug users in treatment. (1991) (32)
- PTSD and depression as predictors of physical health-related quality of life in tobacco-dependent veterans. (2012) (31)
- Urine Screening for Marijuana Among Methadone-Maintained Patients (1993) (30)
- Effects of psychiatric care for dual diagnosis patients treated in a drug dependence clinic. (1995) (30)
- Smoking cessation treatment among dually diagnosed individuals: preliminary evaluation of different pharmacotherapies. (2003) (30)
- Provider and patient perspectives on barriers to buprenorphine adherence and the acceptability of video directly observed therapy to enhance adherence (2019) (29)
- Methadone medical maintenance in primary care. An implementation evaluation. (2005) (29)
- Women in addictions treatment: comparing VA and community samples. (2002) (28)
- The Influence of Posttraumatic Stress Disorder Numbing and Hyperarousal Symptom Clusters in the Prediction of Physical Health Status in Veterans With Chronic Tobacco Dependence and Posttraumatic Stress Disorder (2011) (28)
- Prevalence of Alcohol Misuse and Follow-Up Care in a National Sample of OEF/OIF VA Patients With and Without TBI. (2017) (28)
- Smoking intensity and severity of specific symptom clusters in posttraumatic stress disorder. (2012) (27)
- Electronic Medical Record Alert Associated With Reduced Opioid and Benzodiazepine Coprescribing in High-risk Veteran Patients (2018) (27)
- Disulfiram use in patients with abnormal liver function test results. (1998) (27)
- Alcohol-Related Nurse Care Management in Primary Care: A Randomized Clinical Trial (2018) (27)
- Extended-release naltrexone and harm reduction counseling for chronically homeless people with alcohol dependence. (2015) (27)
- Outcome of contingency contracting for illicit drug use in a methadone maintenance program. (1993) (27)
- Survey of Primary Care and Mental Health Prescribers’ Perspectives on Reducing Opioid and Benzodiazepine Co-Prescribing Among Veterans (2016) (27)
- Quetiapine for the Treatment of Cocaine Dependence: An Open-Label Trial (2008) (27)
- Personality disorder subtypes among opiate addicts in methadone maintenance. (1996) (27)
- Smoking outcome expectancies in military veteran smokers with posttraumatic stress disorder. (2012) (25)
- Quetiapine and false-positive urine drug testing for tricyclic antidepressants. (2000) (24)
- Treatment outcomes in opioid dependent patients with different buprenorphine/naloxone induction dosing patterns and trajectories. (2015) (24)
- A polymorphism in the OPRM1 3′ untranslated region is associated with methadone efficacy in treating opioid dependence (2016) (23)
- Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology. (2013) (23)
- Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems. (2020) (22)
- Single Dose of 24 Milligrams of Buprenorphine for Heroin Detoxification: An Open-label Study of Five Inpatients (2006) (20)
- A system for uniform application of contingencies for illicit drug use. (1987) (19)
- Urine Screening Practices in Methadone Maintenance Clinics: A Survey of How the Results are Used (1991) (19)
- Reporting of HIV risk behaviors by injection drug using heterosexual couples in methadone maintenance. (1994) (18)
- Alcohol use and high-risk behavior by intravenous drug users in an AIDS education paradigm. (1992) (18)
- Causes of death and expected years of life lost among treated opioid-dependent individuals in the United States and Taiwan. (2017) (18)
- Validity of the MCMI Drug Abuse Scale with drug abusing and psychiatric samples. (1990) (17)
- Extended‐release naltrexone (XR‐NTX) for opioid use disorder in clinical practice: Vivitrol's Cost and Treatment Outcomes Registry (2018) (17)
- Patient-centered primary care for adults at high risk for AUDs: the Choosing Healthier Drinking Options In primary CarE (CHOICE) trial (2017) (17)
- High-Risk Drinking and Academic Performance among College Student Veterans. (2014) (17)
- The Role of Cannabis Legalization in the Opioid Crisis. (2018) (16)
- Further validation of the alcohol dependence scale as an index of severity. (2007) (16)
- The Alcohol Use Disorders Identification Test (AUDIT) Predicts Alcohol Withdrawal Symptoms During Inpatient Detoxification (2002) (16)
- Staffing patterns of American methadone maintenance programs. (1990) (16)
- Escalating Opioid Dose Is Associated With Mortality: A Comparison of Patients With and Without Opioid Use Disorder (2019) (15)
- PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment (2021) (15)
- Open Trial of Injectable Risperidone for Methamphetamine Dependence (2009) (15)
- A comparison of methamphetamine-dependent inpatients childhood attention deficit hyperactivity disorder symptomatology. (2005) (15)
- Survey of providers' attitudes toward integrating smoking cessation treatment into posttraumatic stress disorder care. (2013) (15)
- Methadone medical maintenance in primary care (2005) (15)
- Co-occurring substance use disorders and PTSD. (2015) (14)
- Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial (2021) (14)
- New Coprescription of Opioids and Benzodiazepines and Mortality Among Veteran Affairs Patients With Posttraumatic Stress Disorder. (2019) (14)
- Detecting Bipolar Disorder Among Treatment-Seeking Substance Abusers (2000) (14)
- Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2 years: Results from a multisite randomized trial of adults with opioid use disorder. (2019) (13)
- Risk Factors Associated with HCV Among Opioid-Dependent Patients in a Multisite Study (2015) (13)
- Marijuana use by methadone maintenance patients. (1990) (13)
- Using the General Behavior Inventory to Screen for Mood Disorders Among Patients With Psychoactive Substance Dependence (1994) (13)
- Comparative Safety of Benzodiazepines and Opioids Among Veterans Affairs Patients With Posttraumatic Stress Disorder (2013) (13)
- Acceptability and Feasibility of a Mobile Health Application for Video Directly Observed Therapy of Buprenorphine for Opioid Use Disorders in an Office-based Setting. (2020) (13)
- Providing Intensive Addiction/Housing Case Management to Homeless Veterans Enrolled in Addictions Treatment: A Randomized Controlled Trial (2017) (12)
- Validity of the MCMI Drug Abuse Scale varies as a function of drug choice, race, and axis II subtypes. (1991) (12)
- Medications to treat cocaine use disorders: current options. (2019) (12)
- An innovative approach to reducing cannabis use in a subset of methadone maintenance clients. (1999) (12)
- Using Drugs to Facilitate Sexual Behavior Is Associated with Sexual Variety among Injection Drug Users (1993) (12)
- Longitudinal analysis of the relationship between PTSD symptom clusters, cigarette use, and physical health-related quality of life (2013) (12)
- Preliminary findings: Contingency management targeting psycho-stimulant use results in secondary decreases in smoking for severely mentally ill adults. (2014) (11)
- Use of a learning collaborative to support implementation of integrated care for smoking cessation for veterans with posttraumatic stress disorder. (2014) (11)
- Users of free treatment slots at a community-based methadone maintenance clinic. (1995) (10)
- Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III). (2021) (10)
- A nationwide survey of urinalysis practices of methadone maintenance clinics. Utilization of laboratory services. (1990) (10)
- Video directly observed therapy intervention using a mobile health application among opioid use disorder patients receiving office-based buprenorphine treatment: protocol for a pilot randomized controlled trial (2020) (10)
- Characteristics and Service Utilization of Homeless Veterans Entering VA Substance Use Treatment (2017) (10)
- Mood Disorders and Risk of Lung Cancer in the EAGLE Case-Control Study and in the U.S. Veterans Affairs Inpatient Cohort (2012) (10)
- Trends in Prescriptions for Non-opioid Pain Medications among U.S. Adults with Moderate or Severe Pain, 2014-2018. (2022) (10)
- Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Nonaddiction Clinics in the US Veterans Health Care System (2021) (9)
- Cost-Effectiveness of Integrating Tobacco Cessation Into Post-Traumatic Stress Disorder Treatment. (2016) (9)
- Returning Veterans With Addictions (2011) (9)
- Tobacco use trajectories among a large cohort of treated smokers with posttraumatic stress disorder. (2015) (9)
- Medication-assisted therapy for opioid addiction. (2013) (9)
- Psychiatric comorbidity and treatment outcomes in patients with opioid use disorder: Results from a multisite trial of buprenorphine-naloxone and methadone. (2021) (9)
- Harm reduction with pharmacotherapy for homeless people with alcohol dependence: protocol for a randomized controlled trial. (2014) (9)
- Harm reduction treatment for smoking (HaRT-S): findings from a single-arm pilot study with smokers experiencing chronic homelessness. (2019) (8)
- Video directly observed therapy for patients receiving office-based buprenorphine - A pilot randomized controlled trial. (2021) (8)
- Clinical monitoring and high-risk conditions among patients with SUD newly prescribed opioids and benzodiazepines. (2014) (8)
- Clinical leaders and providers’ perspectives on delivering medications for the treatment of opioid use disorder in Veteran Affairs’ facilities (2021) (8)
- Prevalence of Medical Cannabis Use and Associated Health Conditions Documented in Electronic Health Records Among Primary Care Patients in Washington State (2021) (8)
- Secondary Analysis of Pain Outcomes in a Large Pragmatic Randomized Trial of Buprenorphine/Naloxone Versus Methadone for Opioid Use Disorder (2020) (8)
- Evaluation of a minimal services treatment track for noncompliant patients in opioid substitution treatment. (2003) (8)
- Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients (2022) (7)
- Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems (2021) (7)
- Can an immunoassay become a standard technique in detecting oxycodone and its metabolites? (2005) (7)
- Quetiapine for the treatment of cocaine use disorder. (2015) (7)
- The Management of Substance Use Disorders: Synopsis of the 2021 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline (2022) (7)
- Tobacco Use Treatment in Primary Care Patients with Psychiatric Illness (2014) (7)
- Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: a randomised clinical trial. (2021) (7)
- Marijuana not ready for prime time as an analgesic. (2014) (6)
- A Guide for Applying to Addiction Psychiatry Fellowship (2019) (6)
- Mental health after deployment to Iraq or Afghanistan. (2006) (6)
- Substance use disorders and COVID-19: An analysis of nation-wide Veterans Health Administration electronic health records (2022) (6)
- Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report (2020) (6)
- Methadone and Buprenorphine: The Place of Opiate Replacement Therapies (2016) (5)
- Use of Prolonged Exposure and Sertraline in the Treatment of Posttraumatic Stress Disorder for Veterans. (2019) (5)
- Pain, cannabis use, and physical and mental health indicators among veterans and non-veterans: results from National Epidemiologic Survey on Alcohol and Related Conditions-III. (2021) (5)
- Commentary on Burns et al. (2015): retention in buprenorphine treatment. (2015) (5)
- Relationship of Phosphatidylethanol (PEth) Biomarker to Self-Reported Alcohol Drinking Patterns in Older and Middle Age Adults. (2020) (5)
- Transporting efficacious treatments from academia to community: barriers and opportunities. (2003) (5)
- Pharmacokinetic profile of an oral loading dose of divalproex sodium during acute alcohol withdrawal. (2006) (4)
- Clinical Documentation of Patient-Reported Medical Cannabis Use in Primary Care: Toward Scalable Extraction Using Natural Language Processing Methods (2022) (4)
- Trends in Cannabis Use Disorder Diagnoses in the U.S. Veterans Health Administration, 2005-2019. (2022) (4)
- Comparison of HIV‐Associated Risk Behaviors of Primary Intravenous Stimulant Users and Opioid‐Addicted Subjects on Methadone Maintenance (1992) (4)
- Outcome of a second episode of methadone maintenance. (1996) (4)
- The Unmet Challenges of Co-Occurring Alcohol and Opioid Use. (2018) (4)
- Primary Care and Mental Health Prescribers, Key Clinical Leaders, and Clinical Pharmacist Specialists' Perspectives on Opioids and Benzodiazepines. (2021) (4)
- A pilot study comparing severely and persistently mentally ill opiate-addicted patients in dual-diagnosis treatment with patients in methadone maintenance. (1998) (3)
- Use of Veterans Affairs Health Care Services by Veterans Receiving Addiction Treatment in Washington State. (2004) (3)
- Authors' reply: "Risk reduction with buprenorphine-naloxone and methadone: patient's choice". (2014) (3)
- The Use of Urine Toxicology to Enhance Patient Control of Take-Home Doses in Methadone Maintenance: Effects on Reducing Illicit Drug Use (1998) (3)
- Non-pharmacological Treatment for Chronic Pain in US Veterans Treated Within the Veterans Health Administration: Implications for Expansion in US Healthcare Systems (2022) (3)
- Prevalence and Medication Treatment of Opioid Use Disorder Among Primary Care Patients with Hepatitis C and HIV (2021) (3)
- Smoking cessation treatment among dually diagnosed individuals (2003) (3)
- Needle obtainment and cleaning habits of addicts. (1989) (3)
- Long-term Follow-up Assessment of Opioid Use Outcomes among Individuals with Comorbid Mental Disorders and Opioid Use Disorder Treated with Buprenorphine or Methadone in a Randomized Clinical Trial. (2021) (3)
- Acceptability, feasibility, and outcomes of a clinical pilot program for video observation of methadone take-home dosing during the COVID-19 pandemic (2022) (2)
- Integrating Routine Screening for Opioid Use Disorder into Primary Care Settings: Experiences from a National Cohort of Clinics (2022) (2)
- Long-term Buprenorphine Treatment for Loperamide Use Disorder: A Case Series (2020) (2)
- Medications for use in alcohol rehabilitation (2014) (2)
- Effect of a Care Management Intervention on 12-Month Drinking Outcomes Among Patients With and Without DSM-IV Alcohol Dependence at Baseline (2019) (2)
- Addict beliefs about access to HIV test results. (1989) (2)
- Potential for Precision Medicine in Methadone Treatment of Opioid Use Disorder. (2020) (2)
- Comparative safety of methadone and buprenorphine. (2015) (2)
- Sex Differences in Comorbid Mental and Substance Use Disorders Among Primary Care Patients With Opioid Use Disorder. (2022) (2)
- Comparing mental and physical health of U.S. veterans by VA healthcare use: implications for generalizability of research in the VA electronic health records (2022) (2)
- Next steps in addressing the prevention, screening, and treatment of substance use disorder in active duty and veteran Operation Enduring Freedom and Operation Iraqi Freedom populations. (2012) (2)
- Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans (2022) (1)
- LONG-SUFFERING OR PROLONGED SUFFERING? TIME MATTERS (2009) (1)
- Contingency management targeting psychostimulant use results in secondary decreases in smoking for severely mentally ill adults (2014) (1)
- Induction onto extended-release naltrexone in 302 cocaine-dependent opioid users (2014) (1)
- State-of-The-Art Treatment of Opioid Use Disorder (2019) (1)
- Methadone “callbacks” within a veterans affairs opioid treatment program: Detecting methadone misuse (2017) (1)
- Pain, cannabis use, and physical and mental health indicators among veterans and nonveterans (1)
- Imperative for Attention to Opioid Use Disorder and Other Substance Use Disorders in Older Adults. (2021) (1)
- Intrinsic clustering of treatment outcome in recovery from opioid use disorder: Results from starting treatment with agonist replacement therapies (2015) (1)
- Tobacco use data questioned in veterans study. (2010) (1)
- Genetic Determinants of Addiction to Alcohol, Tobacco, and Drugs of Abuse (2006) (1)
- Causes of death and expected years of life lost among opioid-dependent individuals using agonist therapy in the U.S. and Taiwan (2017) (1)
- Treatment of opioid dependence (2013) (1)
- Controversies in Marijuana Legalization: Taking the High Road (2015) (1)
- A randomized controlled clinical trial of prazosin for alcohol use disorder in active duty soldiers: Predictive effects of elevated cardiovascular parameters. (2023) (1)
- “Now, I am Empowered. Now, I am a Woman With Spirit”: Evaluating CARE’s Public Health Work Through a Community-Organizing Framework in Sri Lanka and Bangladesh (2020) (1)
- Elevated customary alcohol consumption attenuates opioid effects (2021) (1)
- Effects of Buprenorphine Dose and Therapeutic Engagement on Illicit Opiate Use in Opioid Use Disorder Treatment Trials (2022) (1)
- A survey of how urinalysis results are utilized by methadone maintenance clinics (1988) (0)
- Clarification of Benzodiazepine Structural Classes: Reply (1995) (0)
- Rapid mixed-methods formative evaluation to identify and act on implementation barriers and facilitators and optimize integration of opioid use disorder treatment in primary care (2019) (0)
- Correlates of Long-Term Opioid Abstinence After Randomization to Methadone Versus Buprenorphine/Naloxone in a Multi-Site Trial (2018) (0)
- State Cannabis Legalization and Cannabis Use Disorder in the US Veterans Health Administration, 2005 to 2019 (2023) (0)
- Buprenorphine Use and Courses of Care for Opioid Use Disorder Treatment Within the Veterans Health Administration (2023) (0)
- Special issues in office-based opioid treatment (2014) (0)
- APA Council Reports. (2018) (0)
- Prazosin for Alcohol Use Disorder: Response to Kleinman and Ostacher. (2019) (0)
- 2733 – Quetiapine for the Treatment of Cocaine Dependence (2013) (0)
- Effect of Prazosin and Naltrexone on Alcohol Craving and Alcohol Consumption in Veterans and Service Members with and without PTSD (2019) (0)
- Cocaine Use Reduction with Buprenorphine (CURB): Study methods and participant characteristics (2014) (0)
- Marijuana—Legal, But Not by Prescription (2015) (0)
- TABLE 2—Correspondence Between Self-Identification in Response to Forced-Choice Question and Racial/Ethnic Designation in Registration Database: New York City, 2000-2001 (2003) (0)
- Use of Video Directly Observed Therapy and Characteristics Associated With Use Among Patients Treated With Buprenorphine in an Office-based Setting. (2022) (0)
- The Next Stage of Buprenorphine Care for Opioid Use Disorder (2019) (0)
- A survey of urinalysis screening policies among methadone maintenance clinics (1988) (0)
- Methamphetamine use and illicit opioid use during buprenorphine treatment (2023) (0)
- Attenuated opioid analgesia to experimental pain in cannabis users (2021) (0)
- The Addiction Solution: Treating Our Dependence on Opioids and Other Drugsby Lloyd I. Sederer, M.D. New York, Simon & Schuster, 2018, 224 pp., $26.00 (hardcover). (2018) (0)
- Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment (2022) (0)
- Baseline representativeness of patients in clinics enrolled in the PRimary care Opioid Use Disorders treatment (PROUD) trial: comparison of trial and non-trial clinics in the same health systems (2022) (0)
- Care coordination between rural primary care and telemedicine to expand medication treatment for opioid use disorder: Results from a single-arm, multisite feasibility study. (2023) (0)
- Early implementation outcomes from the supporting primary care providers in opioid risk reduction and treatment (SUPPORT) center (2019) (0)
- Short communication Brief motivational feedback improves post-incarceration treatment contact among veterans with substance use disorders (2003) (0)
- Clinician Perspectives on Delivering Medication Treatment for Opioid Use Disorder during the COVID-19 Pandemic: A Qualitative Evaluation. (2023) (0)
- VA Researchers Test Integrated Care Model for Substance-Abusing Patients: (578422006-005) (2001) (0)
- Dopamine and depression. (2007) (0)
- Safety of combination buprenorphine/naloxone and extended release naltrexone (2017) (0)
- Buprenorphine-naloxone vs. methadone: Equal HIV risk reduction in start (2014) (0)
- Addiction Services for Veterans: Opportunities in Acute Care (2022) (0)
- Substance Use Disorders: Alcohol, Stimulants, and Opioids (2016) (0)
- Moderation of buprenorphine therapy for cocaine dependence efficacy by variation of the Prodynorphin gene (2022) (0)
- Effects of education on high risk HIV transmission behaviors. (1990) (0)
- Clinical Issues Related to the Costs of Alcoholism (1996) (0)
- The Cocaine Use Reduction with Buprenorphine study: Cocaine use findings (2015) (0)
- COGNITIVE AND SUBJECTIVE EFFECTS OF OXYCODONE IN OLDER ADULTS WITH HEALTHY AND UNHEALTHY ALCOHOL PATTERNS (2019) (0)
- Prevalence,Comorbidity,andPrognosisofMental HealthAmongUSVeterans (2015) (0)
- Introduction to the Special Series: National Drug Abuse Treatment Clinical Trials Network and the Opioid Use Disorder Care Continuum—20 years of research informing practice (2022) (0)
- LETTER TO THE EDITOR (2020) (0)
- Commentary Transporting efficacious treatments from academia to community: barriers and opportunities (2003) (0)
- Buprenorphine in safety-sensitive positions (2022) (0)
- Buprenorphine treatment of opioid dependence: analysis of individual patient data (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Andrew J Saxon?
Andrew J Saxon is affiliated with the following schools:
